Petros Pharmaceuticals, Inc. (PTPI)
PNK · Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
-10.00%
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
Market Cap
$152,540.14
Shares Outstanding
42.4M
Exchange
PNK
Currency
USD
About Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | ||||
| Operating Income | -1.8M | -991K | -391K | -1.0M |
| Net Income | 5.4M | -923K | -337K | -987K |
| Diluted EPS | $-1.29 | $-0.03 | $nan | $-0.03 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 6.0M | 5.8M | 0.00 | 0.00 |
| Gross Profit | 3.7M | 4.2M | 0.00 | 0.00 |
| Operating Income | -15.8M | -10.8M | -4.6M | -4.6M |
| Net Income | -20.0M | -8.2M | -14.3M | 1.9M |
| Diluted EPS | $-242.00 | $-158.75 | $-83.47 | $-1.56 |